Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Glycemic Control on Skeletal Outcomes in Adults With Type 1 Diabetes : DenSiFy (Diabetes Spine Fractures) Cohort

NCT06351176 is registered in ClinicalTrials.gov with CHU de Quebec-Universite Laval as lead sponsor.

NCT NCT06351176
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06351176 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Glycemic Control on Skeletal Outcomes in Adults With Type 1 Diabetes : DenSiFy (Diabetes Spine Fractures) Cohort
Lead sponsor
CHU de Quebec-Universite Laval
Phase
Observational
Overall status
Unknown status
Start date
July 4, 2023
Completion date
August 29, 2025
Enrollment
163 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bone diseases, metabolic, bone health, bone loss, diabetes mellitus, type 1, hyperglycaemia due to type 1 diabetes mellitus